Article
Genetic evolution of T-cell resistance in the course of melanoma progression.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Dec 2014
Sucker Antje, Zhao Fang, Real Birgit, Heeke Christina, Bielefeld Nicola, Maβen Stefan, Horn Susanne, Moll Iris, Maltaner Raffaela, Horn Peter A, Schilling Bastian, Sabbatino Francesco, Lennerz Volker, Kloor Matthias, Ferrone Soldano, Schadendorf Dirk, Falk Christine S, Griewank Klaus, Paschen Annette
Abstract excerpt
PURPOSE: CD8(+) T lymphocytes can kill autologous melanoma cells, but their activity is impaired when poorly immunogenic tumor phenotypes evolve in the course of disease progression. Here, we analyzed three consecutive melanoma lesions obtained within one year of developing stage IV disease for their recognition by autologous T cells. EXPERIMENTAL DESIGN: One skin (Ma-Mel-48a) and two lymph node (Ma-Mel-48b,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
